Nicotinic regulation of microglia: potential contributions to addiction
Journal of Neural Transmission · 2024-05 · 131 (5) · 425-435
DOI: 10.1007/s00702-023-02703-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neural Transmission, online erschienen am 01.10.2023. Verfasst von Alexa R Soares und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Yale University, 34 Park Street-3rd floor Research, New Haven, CT, 06508, USA. Hauptthemen laut MEDLINE: Microglia, Nicotine, Tobacco Use Disorder. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIAAA NIH HHS, NIDA NIH HHS.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Clinical and preclinical studies have identified immunosuppressive effects of nicotine, with potential implications for treating nicotine addiction. Here we review how nicotine can regulate microglia, the resident macrophages in the brain, and corresponding effects of nicotine on neuroimmune signaling. There is significant evidence that activation of α7 nicotinic acetylcholine receptors (nAChRs) on microglia can trigger an anti-inflammatory cascade that alters microglial polarization and activity, cytokine release, and intracellular calcium concentrations, leading to neuroprotection. These anti-inflammatory effects of nicotine-dependent α7 nAChR signaling are lost during withdrawal, suggesting that neuroimmune signaling is potentiated during abstinence, and thus, heightened microglial activity may drive circuit disruption that contributes to withdrawal symptoms and hyperkatifeia. In sum, the clinical literature has highlighted immunomodulatory effects of nicotine and the potential for anti-inflammatory compounds to treat addiction. The preclinical literature investigating the underlying mechanisms points to a role of microglial engagement in the circuit dysregulation and behavioral changes that occur during nicotine addiction and withdrawal, driven, at least in part, by activation of α7 nAChRs on microglia. Specifically targeting microglial signaling may help alleviate withdrawal symptoms in people with nicotine dependence and help to promote abstinence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Yale University, 34 Park Street-3rd floor Research, New Haven, CT, 06508, USA.
- Interdepartmental Neuroscience Program, Yale University School of Medicine, New Haven, CT, 06508, USA.
- Department of Psychiatry, Yale University, 34 Park Street-3rd floor Research, New Haven, CT, 06508, USA. marina.picciotto@yale.edu.
- Interdepartmental Neuroscience Program, Yale University School of Medicine, New Haven, CT, 06508, USA. marina.picciotto@yale.edu.
ORCID-Profile: Marina R Picciotto
Förderung
- NIMH NIH HHS
- NIAAA NIH HHS
- NIDA NIH HHS
- National Institute on Drug Abuse
- National Institute on Alcohol Abuse and Alcoholism
Zitieren
APA
Soares, A. R., & Picciotto, M. R. (2024). Nicotinic regulation of microglia: potential contributions to addiction. Journal of Neural Transmission, 131(5), 425-435. https://doi.org/10.1007/s00702-023-02703-9
Vancouver
Soares AR, Picciotto MR. Nicotinic regulation of microglia: potential contributions to addiction. Journal of Neural Transmission. 2024;131(5):425-435. doi:10.1007/s00702-023-02703-9
BibTeX
@article{Soares2024,
author = {Soares, Alexa R and Picciotto, Marina R},
title = {Nicotinic regulation of microglia: potential contributions to addiction},
journal = {Journal of Neural Transmission},
year = {2024},
volume = {131},
number = {5},
pages = {425--435},
doi = {10.1007/s00702-023-02703-9}
}
EUVIMED